Drug Topics - March 2009 - (Page 41)

AMA PRA Category Credit CE CREDIT: 2.0 EARN CME CREDIT FOR THIS ACTIVITY AT WWW.DRUGTOPICS.COM E DU CATIO NAL O BJ E CTIV E S Goal: To increase pharmacists’ understanding of the newer, biologic agents used for the management of rheumatoid arthritis. After participating in this activity, pharmacists should be able to: Describe the epidemiology and pathophysiology of rheumatoid arthritis (RA). Identify the clinical presentation of RA, including common signs and symptoms and extra-articular manifestations. Identify diagnostic criteria for RA and classify a given patient. Explain current pharmacologic treatment strategies for the management of RA. Discuss the role of the newer, biologic agents used for the management of RA, including their dosing, mechanisms of action, adverse drug effects, monitoring parameters, and special warnings. Provide appropriate nonpharmacologic and pharmacologic recommendations and monitoring parameters for a given patient with RA. The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE # 012-999-09-008-H01-P ACPE # 012-999-09-008-H01-T This lesson is no longer valid for CE credit after 3/31/2011. To obtain immediate CE credit, take the test on-line at www.drugtopics.com. Just click on the “Continuing Education” box on the Drug Topics home page, which will take you to the CE site. Log in, find and click on this lesson, and follow the three simple steps. Test results will be displayed immediately and you can print the certificate showing your earned CE credits. The author discloses that she has no nancial relationship with any manufacturer in this area of medicine. For questions concerning PRINT CEs, call (352) 273-6275. For questions concerning ON-LINE CEs, call (866) 261-3558. W W W.D R U GTO P I C S .C O M March 2009 DRUG TOPICS 41 http://WWW.DRUGTOPICS.COM http://www.drugtopics.com http://WWW.DRUGTOPICS.COM Table of Contents for the Digital Edition of Drug Topics - March 2009Drug Topics - March 2009ContentsLettersUp FrontUp Front in DepthCommentary2009 DT Salary SurveySpecial ReportOTC-- DT's Eye Care Survey ResultsBiologic AgentsFDA SafetyNew ProductsViewpointDrug Topics - March 2009Drug Topics - March 2009 - Drug Topics - March 2009 (Page Cover1)Drug Topics - March 2009 - Drug Topics - March 2009 (Page Cover2)Drug Topics - March 2009 - Drug Topics - March 2009 (Page 1)Drug Topics - March 2009 - Drug Topics - March 2009 (Page 2)Drug Topics - March 2009 - Contents (Page 3)Drug Topics - March 2009 - Contents (Page 4)Drug Topics - March 2009 - Contents (Page 5)Drug Topics - March 2009 - Contents (Page 6)Drug Topics - March 2009 - Contents (Page 7)Drug Topics - March 2009 - Contents (Page 8)Drug Topics - March 2009 - Contents (Page H1)Drug Topics - March 2009 - Contents (Page H2)Drug Topics - March 2009 - Contents (Page H3)Drug Topics - March 2009 - Contents (Page H4)Drug Topics - March 2009 - Contents (Page H5)Drug Topics - March 2009 - Contents (Page H6)Drug Topics - March 2009 - Contents (Page H7)Drug Topics - March 2009 - Contents (Page H8)Drug Topics - March 2009 - Contents (Page H9)Drug Topics - March 2009 - Contents (Page H10)Drug Topics - March 2009 - Contents (Page H11)Drug Topics - March 2009 - Contents (Page H12)Drug Topics - March 2009 - Contents (Page 9)Drug Topics - March 2009 - Contents (Page 10)Drug Topics - March 2009 - Letters (Page 11)Drug Topics - March 2009 - Up Front (Page 12)Drug Topics - March 2009 - Up Front (Page 13)Drug Topics - March 2009 - Up Front in Depth (Page 14)Drug Topics - March 2009 - Up Front in Depth (Page 15)Drug Topics - March 2009 - Commentary (Page 16)Drug Topics - March 2009 - Commentary (Page 17)Drug Topics - March 2009 - Commentary (Page 18)Drug Topics - March 2009 - Commentary (Page 19)Drug Topics - March 2009 - 2009 DT Salary Survey (Page 20)Drug Topics - March 2009 - 2009 DT Salary Survey (Page 21)Drug Topics - March 2009 - 2009 DT Salary Survey (Page 22)Drug Topics - March 2009 - 2009 DT Salary Survey (Page 23)Drug Topics - March 2009 - 2009 DT Salary Survey (Page 24)Drug Topics - March 2009 - Special Report (Page 25)Drug Topics - March 2009 - Special Report (Page 26)Drug Topics - March 2009 - Special Report (Page 27)Drug Topics - March 2009 - Special Report (Page 28)Drug Topics - March 2009 - Special Report (Page 29)Drug Topics - March 2009 - Special Report (Page 30)Drug Topics - March 2009 - Special Report (Page 31)Drug Topics - March 2009 - Special Report (Page 32)Drug Topics - March 2009 - Special Report (Page 33)Drug Topics - March 2009 - OTC-- DT's Eye Care Survey Results (Page 34)Drug Topics - March 2009 - OTC-- DT's Eye Care Survey Results (Page 35)Drug Topics - March 2009 - OTC-- DT's Eye Care Survey Results (Page 36)Drug Topics - March 2009 - OTC-- DT's Eye Care Survey Results (Page 36a)Drug Topics - March 2009 - OTC-- DT's Eye Care Survey Results (Page 36b)Drug Topics - March 2009 - OTC-- DT's Eye Care Survey Results (Page 37)Drug Topics - March 2009 - OTC-- DT's Eye Care Survey Results (Page 38)Drug Topics - March 2009 - OTC-- DT's Eye Care Survey Results (Page 39)Drug Topics - March 2009 - Biologic Agents (Page 40)Drug Topics - March 2009 - Biologic Agents (Page 41)Drug Topics - March 2009 - Biologic Agents (Page 42)Drug Topics - March 2009 - Biologic Agents (Page 43)Drug Topics - March 2009 - Biologic Agents (Page 44)Drug Topics - March 2009 - Biologic Agents (Page 45)Drug Topics - March 2009 - Biologic Agents (Page 46)Drug Topics - March 2009 - Biologic Agents (Page 47)Drug Topics - March 2009 - Biologic Agents (Page 48)Drug Topics - March 2009 - Biologic Agents (Page 49)Drug Topics - March 2009 - FDA Safety (Page 50)Drug Topics - March 2009 - FDA Safety (Page 51)Drug Topics - March 2009 - New Products (Page 52)Drug Topics - March 2009 - New Products (Page 53)Drug Topics - March 2009 - New Products (Page 54)Drug Topics - March 2009 - New Products (Page 55)Drug Topics - March 2009 - New Products (Page 56)Drug Topics - March 2009 - New Products (Page 57)Drug Topics - March 2009 - New Products (Page 58)Drug Topics - March 2009 - New Products (Page 59)Drug Topics - March 2009 - Viewpoint (Page 60)Drug Topics - March 2009 - Viewpoint (Page Cover3)Drug Topics - March 2009 - Viewpoint (Page Cover4)http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200912http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200911http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200910http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200909http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200908http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200907http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200906http://digital.modernmedicine.com/nxtbooks/advanstar/dt_200905http://www.nxtbook.com/nxtbooks/advanstar/dt_200904http://www.nxtbook.com/nxtbooks/advanstar/dt_200903http://www.nxtbook.com/nxtbooks/advanstar/dt_200902http://www.nxtbook.com/nxtbooks/advanstar/dt_200901_v2http://www.nxtbook.com/nxtbooks/advanstar/dt_200901http://www.nxtbook.com/nxtbooks/advanstar/dt122908http://www.nxtbook.com/nxtbooks/advanstar/dt122208http://www.nxtbook.com/nxtbooks/advanstar/dt121508http://www.nxtbook.com/nxtbooks/advanstar/dt111008_v2http://www.nxtbook.com/nxtbooks/advanstar/dt120808http://www.nxtbook.com/nxtbooks/advanstar/dt120108http://www.nxtbook.com/nxtbooks/advanstar/dt112408http://www.nxtbook.com/nxtbooks/advanstar/dt111708http://www.nxtbook.com/nxtbooks/advanstar/dt111008http://www.nxtbook.com/nxtbooks/advanstar/dt110308http://www.nxtbook.com/nxtbooks/advanstar/dt102708http://www.nxtbook.com/nxtbooks/advanstar/dt102008http://www.nxtbook.com/nxtbooks/advanstar/dt101308http://www.nxtbook.com/nxtbooks/advanstar/dt100608http://www.nxtbook.com/nxtbooks/advanstar/dt092908http://www.nxtbook.com/nxtbooks/advanstar/dt092208http://www.nxtbook.com/nxtbooks/advanstar/dt090808http://www.nxtbook.com/nxtbooks/advanstar/dt090108http://www.nxtbook.com/nxtbooks/advanstar/dt082508http://www.nxtbook.com/nxtbooks/advanstar/dt081808http://www.nxtbook.com/nxtbooks/advanstar/dt081108http://www.nxtbook.com/nxtbooks/advanstar/dt080408http://www.nxtbook.com/nxtbooks/advanstar/dt072808http://www.nxtbook.com/nxtbooks/advanstar/dt072108http://www.nxtbook.com/nxtbooks/advanstar/dt070708http://www.nxtbook.com/nxtbooks/advanstar/dt063008http://www.nxtbook.com/nxtbooks/advanstar/dt062308http://www.nxtbook.com/nxtbooks/advanstar/dt061608http://www.nxtbook.com/nxtbooks/advanstar/dt060908http://www.nxtbook.com/nxtbooks/advanstar/dt060208http://www.nxtbook.com/nxtbooks/advanstar/dt052608http://www.nxtbook.com/nxtbooks/advanstar/dt051908http://www.nxtbook.com/nxtbooks/advanstar/dt051208http://www.nxtbook.com/nxtbooks/advanstar/dt042808http://www.nxtbook.com/nxtbooks/advanstar/dt042108http://www.nxtbook.com/nxtbooks/advanstar/dt041408http://www.nxtbook.com/nxtbooks/advanstar/dt040708http://www.nxtbook.com/nxtbooks/advanstar/dt033108http://www.nxtbook.com/nxtbooks/advanstar/dt032408http://www.nxtbook.com/nxtbooks/advanstar/dt031708http://www.nxtbook.com/nxtbooks/advanstar/dt031008http://www.nxtbook.com/nxtbooks/advanstar/dt030308http://www.nxtbook.com/nxtbooks/advanstar/dt022508http://www.nxtbook.com/nxtbooks/advanstar/dt021808http://www.nxtbook.com/nxtbooks/advanstar/dt021108http://www.nxtbook.com/nxtbooks/advanstar/dt020408http://www.nxtbook.com/nxtbooks/advanstar/dt012808http://www.nxtbook.com/nxtbooks/advanstar/dt012108http://www.nxtbook.com/nxtbooks/advanstar/dt011408http://www.nxtbook.com/nxtbooks/advanstar/dt010708http://www.nxtbook.com/nxtbooks/advanstar/dt121707http://www.nxtbook.com/nxtbooks/advanstar/dt121007http://www.nxtbook.com/nxtbooks/advanstar/dt120307http://www.nxtbook.com/nxtbooks/advanstar/dt112607http://www.nxtbook.com/nxtbooks/advanstar/dt111907http://www.nxtbook.com/nxtbooks/advanstar/dt111207http://www.nxtbook.com/nxtbooks/advanstar/dt110507http://www.nxtbook.com/nxtbooks/advanstar/dt102907http://www.nxtbook.com/nxtbooks/advanstar/dt102207http://www.nxtbook.com/nxtbooks/advanstar/dt101507http://www.nxtbook.com/nxtbooks/advanstar/dt100807http://www.nxtbookMEDIA.com

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.